|4.06||+0.26 / +6.84%|
As of 3:59pm ET
|4.01||-0.05 / -1.23%|
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +885.22% increase from the last price of 4.06.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.